Partnerships, Licensing, Investments and M&A Deals and Trends for 2015 in Pharmaceuticals

1
Partnerships, Licensing, Investments and MA
Deals and Trends for 2015 in Pharmaceuticals
Telephone [phone]Mail at
sales_at_researchbeam.com
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
Published on Oct 2014
2


Report Overview

• Partnerships, Licensing, Investments and MA
  Deals and Trends for 2015 in Pharmaceuticals
  report is an essential source of data and trend
  analysis on partnerships, licensing, mergers and
  acquisitions (MAs) and financings in the
  pharmaceuticals industry. The report provides
  detailed information on partnership and licensing
  transactions, MAs, equity/debt offerings,
  private equity, and venture financing registered
  in the pharmaceuticals industry in 2015. The
  report portrays detailed comparative data on the
  number of deals and their value in the last five
  years, subdivided by deal types, various therapy
  areas, and geographies. Additionally, the report
  provides information on the top financial
  advisory firms in the pharmaceuticals industry.
• Data presented in this report is derived from
  proprietary in-house Pharmaceuticals eTrack deals
  database and primary and secondary research.
• Scope
• - Analysis of the market trends for the
  pharmaceutical industry in the global arena.
• - Review of deal trends in the cardiovascular,
  central nervous system, dermatology, ear nose
  throat disorders, gastrointestinal, genito
  urinary system and sex hormones, hematological
  disorders, hormonal disorders, immunology,
  infectious disease, male health, metabolic
  disorders, mouth and dental disorders,
  musculoskeletal, oncology, ophthalmology,
  respiratory, toxicology, and women's health
  segments.
• - Analysis of partnerships, licensing, MAs,
  equity/debt offerings, private equity, and
  venture financing deals in the pharmaceutical
  industry.
• Strategic Focus Report _at_
• http//www.researchbeam.com/partnerships-licensing
  -investments-and-manda-deals-and-trends-for-2015-i
  n-pharmaceuticals-market

3


Report Overview

• - Analysis of therapy areas which are very active
  in terms of venture capital financing,
  partnerships, licensing agreements, equity/debt
  offerings, and MAs.
• - Analysis of deals based on different payment
  modes, including upfront and milestone payments,
  primarily in partnerships and licensing
  agreements in the pharmaceutical industry.
• - Analysis of partnership and licensing deals
  based on clinical stage of development of
  products.
• - Summary of the pharmaceutical deals globally in
  the last five years.
• - Information on the top deals happened in the
  pharmaceutical industry.
• Reasons to Buy
• - Enhance your decision making capability in a
  more rapid and time sensitive manner.
• - Find out the major deal performing segments for
  investments in your industry.
• - Evaluate the types of companies which are
  entering into partnership or licensing
  agreements divesting and acquiring assets.
• - Identify companies that are aggressively
  looking to raise capital in the market
• - Evaluate niche therapy areas that are receiving
  majority of the upfront and milestone payments in
  the pharmaceutical industry.
• - Identify the key venture capitalists, who are
  financing the pharmaceutical and biotech
  companies.
• - Evaluate the clinical development stages where
  majority of the partnerships and licensing
  agreements are happening.

4


Table of Contents
1 Table of Contents1 Table of Contents 21.1
List of Tables 71.2 List of Figures 122
Pharmaceutical Healthcare, Global, Deals
Summary 182.1 Pharmaceutical Healthcare,
Global, Deals Analysis, 2015 182.1.1
Pharmaceuticals Healthcare, Global, Deals
Analysis, 2015 by Quarter 202.2 Pharmaceuticals
Healthcare, Global, by Type, Number of Deals,
2015 222.3 Pharmaceuticals Healthcare, Global,
by Type, Deal Values, 2015 232.4 Pharmaceuticals
Healthcare, Global, Top Deals, 2015 242.5
Pharmaceuticals Healthcare, Top Deals, Global,
Summaries, 2015 252.5.1 Allergan and Pfizer to
Combine in USD160 Billion Deal 252.5.2 Teva
Pharma to Acquire Generics Drug Business from
Allergan for USD40.5 Billion 262.5.3 Actavis
Raises USD21 Billion in Public Offering of Senior
Notes 272.5.4 AbbVie Acquires Pharmacyclics
282.5.5 Pfizer Acquires Hospira for USD17
Billion 292.5.6 Danaher Acquires Pall for
USD13.8 Billion 302.5.7 CVS Health Acquires
Omnicare for USD12.9 Billion 312.5.8
UnitedHealth Acquires Catamaran for USD12.8
Billion 322.5.9 Valeant Pharma Acquires Salix
Pharma for USD10.9 Billion 322.5.10 AbbVie
Raises USD16.7 Billion in Public Offering of
Notes 343 Pharmaceuticals Healthcare, Global,
Top Deal Makers, 2015 354 Pharmaceuticals
Healthcare, Global, Deal Summary, by Type 36
5


Table of Contents
5 Pharmaceuticals Healthcare, Global, Deal
Summary, By Market 91 5.1 Pharmaceuticals
Healthcare, Global, Oncology Deals, 2015 91 5.1.1
Pharmaceuticals Healthcare, Global, Oncology
Deals, 2015 by Quarter 93 5.2 Pharmaceuticals
Healthcare, Global, Central Nervous System Deals,
2015 98 5.2.1 Pharmaceuticals Healthcare,
Global, Central Nervous System Deals, 2015 by
Quarter 100 5.2.2 Central Nervous System - Deals
of the Year 101 5.3 Pharmaceuticals Healthcare,
Global, Infectious Disease Deals, 2015 106 5.3.1
Pharmaceuticals Healthcare, Global, Infectious
Disease Deals, 2015 by Quarter 108 5.3.2
Infectious Disease - Deals of the Year 109 6
Pharmaceuticals Healthcare, Deal Summary, By
Geography 137 6.1 Pharmaceuticals Healthcare,
North America Region, Deals, 2015 137 6.1.2 North
America - Deals of the Year 140 6.2
Pharmaceuticals Healthcare, European Region
Deals, 2015 146 6.2.1 Pharmaceuticals
Healthcare, Europe, Deals, 2015 by Quarter
148 6.2.2 Europe - Deals of the Year 149 6.1.1
Pharmaceuticals Healthcare, North America
Region, Deals, 2015 by Quarter 139 7.1
Pharmaceuticals Healthcare, Global, Top
Financial Advisors, MA, 2015 166 7.2
Pharmaceuticals Healthcare, Global, Top
Financial Advisors, Equity Offerings, 2015 168 8
Further Information 170 8.1 Methodology 170 8.2
About GlobalData 171 8.3 Disclosure information
171
6


Report Ordering
Report Name Partnerships, Licensing,
Investments and MA Deals and Trends for 2015 in
Pharmaceuticals

Product Price
User Price
Single User US 2975
Site User US 7000
Global User US 10500
To View Sample or Purchase Report
7



Contact Us
FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/partnerships-licensing
-investments-and-manda-deals-and-trends-for-2015-i
n-pharmaceuticals-market
Stay With Us At
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com